Bio-Thera Partners With Avalon Pharma For Keytruda Biosimilar In Middle East

The Deal Covers The MENA Region And Saudi Arabia

 
• By Urtė Fultinavičiūtė
  
Bio-Thera and Avalon's deal covers a pembrolizumab biosimilar in the Middle East (Shutterstock)

More from Deals

More from Business